Insider Trading May 15, 2026 05:32 PM

Insider Activity at AMREP CORP Signals Continued Confidence Amid Mixed Analyst Reports

Key shareholders make purchases while a major broker downgrades rating, suggesting internal conviction remains despite external caution.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
AXR

Recent SEC filings show that James H. Dahl, a ten percent owner of AMREP CORP., made an additional purchase of company stock in May 2026. This insider activity occurs against a backdrop of mixed analyst sentiment, highlighted by Freedom Broker downgrading the stock but simultaneously raising its price target.

Insider Activity at AMREP CORP Signals Continued Confidence Amid Mixed Analyst Reports
AXR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Insider purchasing activity by major shareholders (James H. Dahl) indicates internal confidence in AMREP CORP., despite varying external market signals.
  • The recent downgrade of the stock by Freedom Broker to 'Hold' is countered by an increased price target from $23.00 to $30.00, suggesting potential upside perceived by analysts.
  • AMREP’s operational strengths, including a rebound in land sales and steady execution in homebuilding, support its current financial health and market position.

The latest SEC filings reveal that James H. Dahl, who holds a ten percent ownership stake in AMREP CORP. (NASDAQ:AXR), executed a purchase of company shares on May 13, 2026. According to the reported transaction details, Mr. Dahl acquired 1,156 common shares for an approximate total value of $28,580.

The acquisition was structured through several transactions, with individual prices ranging from $24.65 to $24.75 per share. The weighted average price paid for these newly acquired shares amounted to $24.724 per share. Following this specific purchase, Mr. Dahl's direct holdings of common stock increased, bringing his total directly held shares to 488,133.

This notable insider buying activity comes as AMREP’s current trading price is recorded at $25.19, accompanied by a Price-to-Earnings (P/E) ratio of 10.23. Furthermore, the InvestingPro analysis suggests that the stock may be undervalued when compared to its calculated Fair Value. The company's financial standing is rated highly, boasting a

Risks

  • The downgrade of AMREP's stock rating from 'Buy' to 'Hold' by Freedom Broker introduces external caution regarding the company's near-term performance.
  • Investors should note the variation in analyst assessments, where a negative action (downgrade) is paired with a positive adjustment (increased price target), suggesting mixed market views.

More from Insider Trading

Adaptive Biotechnologies Director Sells $1.05M in Stock Under Pre-Arranged Plan Jun 29, 2026 Village Farms CEO Michael DeGiglio Expands Stake Amid Operational Expansion Jun 29, 2026 Broadcom Executive Mark Brazeal Offloads $9.68M in Shares Amid Strategic Corporate Moves Jun 29, 2026 Box Inc. Director Bethany Mayer Offloads $105,561 in Shares Under Pre-Arranged Plan Jun 29, 2026 Werewolf Therapeutics Director Luke Evnin Offloads $47,125 in Shares via Pre-Arranged Plan Jun 29, 2026